TITLE

TAS-102 prolongs overall survival in refractory patients

PUB. DATE
May 2015
SOURCE
BMJ: British Medical Journal;5/23/2015, Vol. 350 Issue 8009, ph2620
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses research being done which examined the use of the oral drug TAS-102 by patients with metastatic colorectal cancer, reported in the "New England Journal of Medicine."
ACCESSION #
102869203

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics